Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow Print PDF (396K) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (36)
Right arrowRequest Permissions
Right arrow Commercial Re-use Guidelines
for Open Access NAR Content
Google Scholar
Right arrow Articles by Lausen, J.
Right arrow Articles by Ryffel, G. U.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lausen, J.
Right arrow Articles by Ryffel, G. U.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nucleic Acids Research, 2000, Vol. 28, No. 2 430-437
© 2000 Oxford University Press

Naturally occurring mutations in the human HNF4{alpha} gene impair the function of the transcription factor to a varying degree

Jörn Lausen, Heike Thomas, Ira Lemm, Michael Bulman1, Michael Borgschulze, Anja Lingott, Andrew T. Hattersley1 and Gerhart U. Ryffel*

Institut für Zellbiologie (Tumorforschung), Universitätsklinikum Essen, Hufelandstraße 55, D-45122 Essen, Germany and 1Department of Vascular Medicine and Diabetes Research, School of Postgraduate Medicine and Health Sciences, University of Exeter, UK

The hepatocyte nuclear factor (HNF)4{alpha}, a member of the nuclear receptor superfamily, regulates genes that play a critical role in embryogenesis and metabolism. Recent studies have shown that mutations in the human HNF4{alpha} gene cause a rare form of type 2 diabetes, maturity onset diabetes of the young (MODY1). To investigate the properties of these naturally occurring HNF4{alpha} mutations we analysed five MODY1 mutations (R154X, R127W, V255M, Q268X and E276Q) and one other mutation (D69A), which we found in HepG2 hepatoma cells. Activation of reporter genes in transfection assays and DNA binding studies showed that the MODY1-associated mutations result in a variable reduction in function, whereas the D69A mutation showed an increased activity on some promoters. None of the MODY mutants acted in a dominant negative manner, thus excluding inactivation of the wild-type factor as a critical event in MODY development. A MODY3-associated mutation in the HNF1{alpha} gene, a well-known target gene of HNF4{alpha}, results in a dramatic loss of the HNF4 binding site in the promoter, indicating that mutations in the HNF4{alpha} gene might cause MODY through impaired HNF1{alpha} gene function. Based on these data we propose a two-hit model for MODY development.

* To whom correspondence should be addressed. Tel: +49 201 723 3110; Fax: +49 201 723 5905; Email: gerhart.ryffel@uni-essen.de Present address: Ira Lemm, McArdle Laboratory for Cancer Research, University of Wisconsin, Madison, WI, USA


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Mol. Endocrinol.Home page
K. L. Egerod, B. Holst, P. S. Petersen, J. B. Hansen, J. Mulder, T. Hokfelt, and T. W. Schwartz
GPR39 Splice Variants Versus Antisense Gene LYPD1: Expression and Regulation in Gastrointestinal Tract, Endocrine Pancreas, Liver, and White Adipose Tissue
Mol. Endocrinol., July 1, 2007; 21(7): 1685 - 1698.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
C. W. Rowley, L. J. Staloch, J. K. Divine, S. P. McCaul, and T. C. Simon
Mechanisms of mutual functional interactions between HNF-4{alpha} and HNF-1{alpha} revealed by mutations that cause maturity onset diabetes of the young
Am J Physiol Gastrointest Liver Physiol, March 1, 2006; 290(3): G466 - G475.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Miura, K. Yamagata, M. Kakei, H. Hatakeyama, N. Takahashi, K. Fukui, T. Nammo, K. Yoneda, Y. Inoue, F. M. Sladek, et al.
Hepatocyte Nuclear Factor-4{alpha} Is Essential for Glucose-stimulated Insulin Secretion by Pancreatic beta-Cells
J. Biol. Chem., February 24, 2006; 281(8): 5246 - 5257.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
J. Ek, C. S. Rose, D. P. Jensen, C. Glumer, K. Borch-Johnsen, T. Jorgensen, O. Pedersen, and T. Hansen
The Functional Thr130Ile and Val255Met Polymorphisms of the Hepatocyte Nuclear Factor-4{alpha} (HNF4A): Gene Associations with Type 2 Diabetes or Altered {beta}-Cell Function among Danes
J. Clin. Endocrinol. Metab., May 1, 2005; 90(5): 3054 - 3059.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
H. Thomas, S. Senkel, S. Erdmann, T. Arndt, G. Turan, L. Klein-Hitpass, and G. U. Ryffel
Pattern of genes influenced by conditional expression of the transcription factors HNF6, HNF4{alpha} and HNF1{beta} in a pancreatic {beta}-cell line
Nucleic Acids Res., November 1, 2004; 32(19): e150 - e150.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
S. Bohn, H. Thomas, G. Turan, S. Ellard, C. Bingham, A. T. Hattersley, and G. U. Ryffel
Distinct Molecular and Morphogenetic Properties of Mutations in the Human HNF1{beta} Gene That Lead to Defective Kidney Development
J. Am. Soc. Nephrol., August 1, 2003; 14(8): 2033 - 2041.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. Hertz, N. Ben-Haim, A. D. Petrescu, B. Kalderon, I. Berman, N. Eldad, F. Schroeder, and J. Bar-Tana
Rescue of MODY-1 by Agonist Ligands of Hepatocyte Nuclear Factor-4{alpha}
J. Biol. Chem., June 13, 2003; 278(25): 22578 - 22585.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
J. Eeckhoute, P. Formstecher, and B. Laine
Maturity-Onset Diabetes of the Young Type 1 (MODY1)-Associated Mutations R154X and E276Q in Hepatocyte Nuclear Factor 4{{alpha}} (HNF4{{alpha}}) Gene Impair Recruitment of p300, a Key Transcriptional Coactivator
Mol. Endocrinol., July 1, 2001; 15(7): 1200 - 1210.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
I. Leclerc, C. Lenzner, L. Gourdon, S. Vaulont, A. Kahn, and B. Viollet
Hepatocyte Nuclear Factor-4{alpha} Involved in Type 1 Maturity-Onset Diabetes of the Young Is a Novel Target of AMP-Activated Protein Kinase
Diabetes, July 1, 2001; 50(7): 1515 - 1521.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
G. Peiler, B. Böckmann, H. Nakhei, and G. U. Ryffel
Inhibitor of the Tissue-Specific Transcription Factor HNF4, a Potential Regulator in Early Xenopus Development
Mol. Cell. Biol., December 1, 2000; 20(23): 8676 - 8683.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
H. Wang, P. Maechler, P. A. Antinozzi, K. A. Hagenfeldt, and C. B. Wollheim
Hepatocyte Nuclear Factor 4alpha Regulates the Expression of Pancreatic beta -Cell Genes Implicated in Glucose Metabolism and Nutrient-induced Insulin Secretion
J. Biol. Chem., November 10, 2000; 275(46): 35953 - 35959.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.